Pharmacotherapeutic follow-up in patients with type 1 diabetes in context of judicialization: possibility optimize costs. (2023). Brazilian Journal of Pharmaceutical Sciences, 59, e23264. https://doi.org/10.1590/s2175-97902023e23264